Maged El-Ghannam

493 total citations
28 papers, 311 citations indexed

About

Maged El-Ghannam is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Maged El-Ghannam has authored 28 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Maged El-Ghannam's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (10 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Maged El-Ghannam is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (10 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Maged El-Ghannam collaborates with scholars based in Egypt, France and Italy. Maged El-Ghannam's co-authors include Sanaa S. Botros, Hanan A El Sayed, James L. Bennett, Tim A. Day, Mohamed Saber, M. K. Hassanein, Mohamed Shemis, Dirk Engels, Ahmed El Ray and M.‐H. Nicolas‐Chanoine and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Tropical Medicine and Hygiene and International Journal for Parasitology.

In The Last Decade

Maged El-Ghannam

24 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maged El-Ghannam Egypt 10 125 90 75 63 59 28 311
Apisit Chaidee Thailand 11 152 1.2× 55 0.6× 82 1.1× 48 0.8× 25 0.4× 22 300
A M el-Hawey Egypt 7 226 1.8× 84 0.9× 74 1.0× 34 0.5× 31 0.5× 15 330
Samar N. El-Beshbishi Egypt 13 272 2.2× 25 0.3× 109 1.5× 83 1.3× 38 0.6× 37 450
Koji Watanabe Japan 5 133 1.1× 129 1.4× 18 0.2× 6 0.1× 22 0.4× 6 325
Heloísa Werneck de Macedo Brazil 12 264 2.1× 78 0.9× 44 0.6× 35 0.6× 18 0.3× 23 355
Mohammad Yousuf Dar India 8 59 0.5× 110 1.2× 33 0.4× 26 0.4× 13 0.2× 10 253
R Nagel Australia 9 205 1.6× 166 1.8× 5 0.1× 7 0.1× 45 0.8× 23 498
Okan Töre Türkiye 9 39 0.3× 30 0.3× 6 0.1× 81 1.3× 177 3.0× 36 323
Cirle Alcantara United States 9 139 1.1× 69 0.8× 3 0.0× 14 0.2× 52 0.9× 10 352
Giacomo Stroffolini Italy 9 16 0.1× 22 0.2× 14 0.2× 5 0.1× 93 1.6× 42 255

Countries citing papers authored by Maged El-Ghannam

Since Specialization
Citations

This map shows the geographic impact of Maged El-Ghannam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maged El-Ghannam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maged El-Ghannam more than expected).

Fields of papers citing papers by Maged El-Ghannam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maged El-Ghannam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maged El-Ghannam. The network helps show where Maged El-Ghannam may publish in the future.

Co-authorship network of co-authors of Maged El-Ghannam

This figure shows the co-authorship network connecting the top 25 collaborators of Maged El-Ghannam. A scholar is included among the top collaborators of Maged El-Ghannam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maged El-Ghannam. Maged El-Ghannam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El-Ghannam, Maged, et al.. (2025). Gut microbiome and gastric cancer: microbial interactions and therapeutic potential. Gut Pathogens. 17(1). 56–56. 2 indexed citations
2.
El-Ghannam, Maged, et al.. (2024). Remarkable alpha-fetoprotein elevation and pseudo-infarction of cirrhotic liver: case report. SHILAP Revista de lepidopterología. 86–91.
3.
El-Ghannam, Maged, et al.. (2024). Oral microbiome dysbiosis and gastrointestinal diseases: a narrative review. SHILAP Revista de lepidopterología. 14(1). 7 indexed citations
4.
El-Ghannam, Maged, et al.. (2023). Helicobacter pylori and oral–gut microbiome: clinical implications. Infection. 52(2). 289–300. 21 indexed citations
5.
El-Ghannam, Maged, et al.. (2023). Oral microbiota and liver diseases. Clinical Nutrition ESPEN. 54. 68–72. 13 indexed citations
6.
Shehab, Hany, et al.. (2023). Assessment of an intraductal metallic stent in the management of postcholecystectomy biliary strictures. PubMed. 2(3). 305–311. 1 indexed citations
7.
El-Ghannam, Maged, et al.. (2022). COVID-19 and liver diseases. SHILAP Revista de lepidopterología. 12(1). 43–43. 6 indexed citations
9.
Ray, Ahmed El, Valérie Paradis, Maged El-Ghannam, et al.. (2022). Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients. SHILAP Revista de lepidopterología. 12(1). 1 indexed citations
10.
El-Ghannam, Maged, et al.. (2021). COVID-19 and Chronic Viral Liver Diseases. Journal of Biosciences and Medicines. 9(9). 138–146. 1 indexed citations
11.
El-Ghannam, Maged, et al.. (2018). Detection of antimicrobial resistance genes of Helicobacter pylori strains to clarithromycin, metronidazole, amoxicillin and tetracycline among Egyptian patients. Egyptian Journal of Medical Human Genetics. 19(4). 417–423. 22 indexed citations
12.
El-Ghannam, Maged, et al.. (2018). Risk scoring systems to predict in-hospital mortality in patients with acute variceal bleeding due to HCV-induced liver cirrhosis. Gastroenterology Insights. 9(1). 7 indexed citations
13.
Shemis, Mohamed, et al.. (2018). Helicobacter pylori Western cagA genotype in Egyptian patients with upper gastrointestinal disease. Egyptian Journal of Medical Human Genetics. 19(4). 297–300. 11 indexed citations
14.
El-Ghannam, Maged. (2017). Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 11(6). OC12–OC16. 4 indexed citations
15.
El‐Ahwany, Eman, et al.. (2016). The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patient. SHILAP Revista de lepidopterología. 8(2). 1994–2000. 1 indexed citations
16.
El-Ghannam, Maged, et al.. (2015). Predictors of In-Hospital Mortality in patients with hepatocellular carcinoma and Acute Variceal bleeding.. SHILAP Revista de lepidopterología. 7(6). 1336–43. 6 indexed citations
17.
Bert, F., Véronique Leflon‐Guibout, Maged El-Ghannam, et al.. (2014). Faecal carriage of extended-spectrumβ-lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France: a comparative epidemiological study. Epidemiology and Infection. 143(6). 1247–1255. 14 indexed citations
18.
Zoheiry, Mona, et al.. (2010). The use of whey protein concentrate in management of chronic hepatitis C virus – a pilot study. Archives of Medical Science. 5(5). 748–755. 6 indexed citations
19.
El-Ghannam, Maged, et al.. (2010). Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C. SHILAP Revista de lepidopterología. 24(10). 597–602. 18 indexed citations
20.
Botros, Sanaa S., et al.. (2005). Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. International Journal for Parasitology. 35(7). 787–791. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026